# Insight Molecular Diagnostics Inc.: filings

IMDX · Nasdaq · CIK 1642380 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/imdx.md) · [Financials](/companies/imdx/financials.md) · [Filings](/companies/imdx/filings.md) · [Insiders](/companies/imdx/insiders.md)

## Reports and events: 266 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 211, 8-K 178, 3 33, 10-Q 32, 424B5 19, UPLOAD 15, CORRESP 14, DEF 14A 13, 10-K 11, SC 13D/A 11, SC 13G 11, DEFA14A 10, EFFECT 10, 4/A 9, D 9, S-3 8, SC 13G/A 8, 10-K/A 7, S-8 7, 424B3 6, 8-K/A 6, PRE 14A 6, SCHEDULE 13D/A 3, SCHEDULE 13G/A 3, 10-12B/A 2, ARS 2, CT ORDER 2, NT 10-K 2, PRE 14C 2, S-1 2, S-1/A 2, S-3/A 2, SEC STAFF LETTER 2, 10-12B 1, 10-12G 1, 25 1, 8-A12B 1, CERT 1, CERTNYS 1, DEF 14C 1, DEFR14A 1, PRER14A 1, RW 1, S-3MEF 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-21 | 16:05 ET | [8-K](/filings/0001493152-26-043560.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-043560 |
| 2026-08-10 | 16:14 ET | [10-Q](/filings/0001642380-26-000011.md) | Quarterly report, period 2026-06-30 | 0001642380-26-000011 |
| 2026-08-10 | 16:10 ET | [8-K](/filings/0001493152-26-036863.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-036863 |
| 2026-06-17 | 16:05 ET | [8-K](/filings/0001493152-26-029078.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-029078 |
| 2026-05-13 | 16:15 ET | [10-Q](/filings/0001642380-26-000008.md) | Quarterly report, period 2026-03-31 | 0001642380-26-000008 |
| 2026-05-13 | 16:10 ET | [8-K](/filings/0001493152-26-022721.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-022721 |
| 2026-05-13 | 16:05 ET | [8-K/A](/filings/0001493152-26-022708.md) | 8.01 Other events | 0001493152-26-022708 |
| 2026-04-30 | 16:14 ET | [DEF 14A](/filings/0001493152-26-020502.md) | Proxy statement, period 2026-04-30 | 0001493152-26-020502 |
| 2026-04-30 | 16:07 ET | [8-K](/filings/0001493152-26-020461.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-020461 |
| 2026-04-27 | 19:14 ET | [SCHEDULE 13D/A](/filings/0000919574-26-002415.md) | Ownership report, active investor, amended | 0000919574-26-002415 |
| 2026-03-26 | 16:13 ET | [10-K](/filings/0001642380-26-000004.md) | Annual report, period 2025-12-31 | 0001642380-26-000004 |
| 2026-03-26 | 16:10 ET | [8-K](/filings/0001493152-26-012915.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-012915 |
| 2026-02-26 | 16:06 ET | [8-K](/filings/0001493152-26-008169.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-008169 |
| 2026-02-12 | 19:52 ET | [SCHEDULE 13D/A](/filings/0000919574-26-000780.md) | Ownership report, active investor, amended | 0000919574-26-000780 |
| 2026-02-12 | 17:20 ET | [8-K](/filings/0001493152-26-006473.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-006473 |
| 2026-02-11 | 08:05 ET | [8-K](/filings/0001493152-26-006117.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-006117 |
| 2025-11-10 | 16:15 ET | [10-Q](/filings/0001193125-25-274266.md) | Quarterly report, period 2025-09-30 | 0001193125-25-274266 |
| 2025-11-10 | 16:11 ET | [8-K](/filings/0001493152-25-021513.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-021513 |
| 2025-10-02 | 16:05 ET | [8-K](/filings/0001493152-25-016685.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-016685 |
| 2025-09-19 | 16:05 ET | [8-K](/filings/0001493152-25-014240.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-014240 |
| 2025-08-11 | 16:11 ET | [10-Q](/filings/0000950170-25-106552.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106552 |
| 2025-08-11 | 16:10 ET | [8-K](/filings/0001641172-25-022974.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-022974 |
| 2025-07-02 | 17:01 ET | [8-K](/filings/0001641172-25-017590.md) | 5.07 Shareholder vote results | 0001641172-25-017590 |
| 2025-06-17 | 07:33 ET | [8-K](/filings/0001641172-25-015338.md) | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015338 |
| 2025-05-14 | 17:07 ET | [DEF 14A](/filings/0001641172-25-010366.md) | Proxy statement, period 2025-05-14 | 0001641172-25-010366 |
| 2025-05-12 | 16:12 ET | [10-Q](/filings/0000950170-25-069213.md) | Quarterly report, period 2025-03-31 | 0000950170-25-069213 |
| 2025-05-12 | 16:10 ET | [8-K](/filings/0001641172-25-009681.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-009681 |
| 2025-04-17 | 17:17 ET | [8-K](/filings/0001641172-25-005288.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-005288 |
| 2025-03-28 | 13:25 ET | [S-1](/filings/0001641172-25-001331.md) | Registration statement | 0001641172-25-001331 |
| 2025-03-24 | 16:16 ET | [10-K](/filings/0000950170-25-043852.md) | Annual report, period 2024-12-31 | 0000950170-25-043852 |
| 2025-03-24 | 16:10 ET | [8-K](/filings/0001641172-25-000283.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-000283 |
| 2025-03-10 | 16:05 ET | [8-K](/filings/0001493152-25-009684.md) | 5.02 Departure or appointment of officers or directors | 0001493152-25-009684 |
| 2025-02-10 | 20:46 ET | [SCHEDULE 13D/A](/filings/0000919574-25-000923.md) | Ownership report, active investor, amended | 0000919574-25-000923 |
| 2025-02-10 | 09:17 ET | [8-K](/filings/0001493152-25-005563.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005563 |
| 2025-01-08 | 16:05 ET | [8-K](/filings/0001493152-25-001389.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-25-001389 |
| 2024-11-12 | 16:08 ET | [10-Q](/filings/0000950170-24-125365.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125365 |
| 2024-11-12 | 16:05 ET | [8-K](/filings/0001493152-24-044741.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-044741 |
| 2024-10-15 | 16:22 ET | [8-K](/filings/0001493152-24-041133.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-24-041133 |
| 2024-10-03 | 06:05 ET | [8-K](/filings/0001493152-24-039269.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039269 |
| 2024-09-25 | 16:09 ET | [DEF 14A](/filings/0001493152-24-038106.md) | Proxy statement, period 2024-09-25 | 0001493152-24-038106 |
| 2024-08-09 | 06:37 ET | [8-K](/filings/0001493152-24-030865.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-24-030865 |
| 2024-08-08 | 16:27 ET | [10-Q](/filings/0001493152-24-030793.md) | Quarterly report, period 2024-06-30 | 0001493152-24-030793 |
| 2024-08-08 | 16:10 ET | [8-K](/filings/0001493152-24-030771.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-030771 |
| 2024-07-12 | 16:05 ET | [8-K](/filings/0001493152-24-027086.md) | 3.01 Delisting notice | 0001493152-24-027086 |
| 2024-07-05 | 16:01 ET | [8-K](/filings/0001493152-24-026335.md) | 5.07 Shareholder vote results; 8.01 Other events | 0001493152-24-026335 |
| 2024-06-17 | 16:10 ET | [8-K](/filings/0001493152-24-024108.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-24-024108 |
| 2024-05-31 | 16:05 ET | [8-K](/filings/0001493152-24-022193.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-022193 |
| 2024-05-23 | 16:05 ET | [8-K](/filings/0001493152-24-021144.md) | 5.02 Departure or appointment of officers or directors | 0001493152-24-021144 |
| 2024-05-15 | 16:21 ET | [8-K](/filings/0001493152-24-019889.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-24-019889 |
| 2024-05-15 | 16:06 ET | [10-Q](/filings/0001493152-24-019842.md) | Quarterly report, period 2024-03-31 | 0001493152-24-019842 |

Page 1 of 6. [Older](/companies/imdx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.